Post resuscitation care. What are the therapeutic alternatives and what do we know?

Resuscitation

Volumn 69, Issue 1, 2006, Pages 15-22

  Herlitz, J ^a   Castren, M ^b   Friberg, H ^c   Nolan, J ^d   Skrifvars, M ^b   Sunde, K ^e   Steen, P A ^e  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c LUND UNIVERSITY   (Sweden)

^d ROYAL UNITED HOSPITAL   (United Kingdom)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cardiac arrest; Post resuscitation; Treatment

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; GLUCOSE; INSULIN; MAGNESIUM; METOPROLOL; PHENYTOIN; POTASSIUM; SOTALOL; THIOPENTAL; VASOACTIVE AGENT;

ACID BASE BALANCE; ACUTE HEART INFARCTION; AFTERCARE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BLOOD CLOT LYSIS; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE MEASUREMENT; BRAIN FUNCTION; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEFIBRILLATOR; DIABETES MELLITUS; DIABETIC PATIENT; DRUG INDICATION; DRUG INFUSION; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; INDUCED HYPOTHERMIA; INSULIN TREATMENT; INTENSIVE CARE; ISCHEMIC HEART DISEASE; LIFE; MAGNESIUM BLOOD LEVEL; MYOCARDIAL DISEASE; NEUROPROTECTION; OUTPATIENT; PATHOPHYSIOLOGY; PATIENT SELECTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; REVASCULARIZATION; REVIEW; RISK REDUCTION; SEIZURE; ST SEGMENT ELEVATION; SUDDEN DEATH; SURVIVAL; THERAPY EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT PLANNING;

HUMANS; INTENSIVE CARE; RESUSCITATION;

EID: 33645879246     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2005.08.006     Document Type: Review

References (65)

1. Eisenberg M.S., and Mengert T. Cardiac resuscitation (review). N Engl J Med 344 (2001) 1304-1313
2. Herlitz J., Bång A., Gunnarsson J., Engdahl J., Karlson B.W., Lindqvist J., et al. Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Göteborg, Sweden. Heart 89 (2003) 25-30
3. Engdahl J., Abrahamsson P., Bång A., Lindqvist J., Karlsson T., and Herlitz J. Is hospital care of major importance for outcome after out-of-hospital cardiac arrest? Experience acquired from patients with out-of-hospital cardiac arrest resuscitated by the same Emergency Medical Service and admitted to one of two hospitals over a 16-year period in the municipality of Göteborg. Resuscitation 43 (2000) 201-211
4. Langhelle A., Tyvold S.S., Lexow K., Hapnes S.A., Sunde K., and Steen P.A. In-hospital factors associated with improved outcome after out-of-hospital cardiac arrest. A comparison between four regions in Norway. Resuscitation 56 (2003) 247-263
5. Laver S., Farrow C., Turner D., and Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 30 (2004) 2126-2128
6. Jørgensen E.O., and Holm S. The course of circulatory and cerebral recovery after circulatory arrest: influence of pre-arrest, arrest and post-arrest factors. Resuscitation 42 (1999) 173-182
7. Grubb N.R., Elton R.A., and Fox K.A.A. In-hospital mortality after out-of-hospital cardiac arrest. Lancet 346 (1995) 417-421
8. Dickey W., and Adgey A.A.J. Mortality within hospital after resuscitation from ventricular fibrillation outside hospital. Br Heart J 67 (1992) 334-338
9. Laurent I., Monchi M., Chiche J.D., Joly L.M., Spaulding C., Bourheois B., et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40 (2002) 2110-2116
10. Voipio V., Kuisma M., Alaspaa A., Manttari M., and Rosenberg P.H. Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest. Resuscitation 49 (2001) 251-258
11. Adrie C., Adib-Conquy M., Laurent I., Monchi M., Vinsonneau C., Fitting C., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106 (2002) 562-568
12. Skrifvars M.B., Pettilä V., Rosenberg P.H., and Castrén M. A multiple logistic regression analysis of in-hospital factors related to survival at six months in patients resuscitated from out-of-hospital ventricular fibrillation. Resuscitation 59 (2003) 319-328
13. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346 (2002) 549-556
14. Bernard S.A., Gray T.W., Buist M.D., Jones B.M., Silvester W., Gutteridge G., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346 (2002) 557-563
15. Holzer M., Bernard S.A., Hachimi-Idrissi S., Roine R.O., Sterz F., Mullner M., and on behalf of the Collaborative Group on Induced Hypothermia for Neuro-protection After Cardiac Arrest. Hypothermia for neuroprotection after cardiac arrest: systematic review and individual patient data meta-analysis (review). Crit Care Med 33 (2005) 414-418
16. Nolan J.P., Morley P.T., Hoek V., and Hickey R.W. Therapeutic hypothermia after Cardiac Arrest. An advisory Statement by the Advanced Life Support Task Force of the International Liaison Committee on Resuscitation. Circulation 108 (2003) 118-121
17. Zeiner A., Holzer M., Sterz F., Schorkhuber W., Eisenburger P., Havel C., et al. Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome. Arch Intern Med 161 (2001) 207-212
18. Müllner M., Sterz F., Binder M., Hellwagner K., Meron G., Herkner H., et al. Arterial blood pressure after human cardiac arrest and neurological recovery. Stroke 27 (1996) 59-62
19. Herlitz J., Ekström L., Wennerblom B., Axelsson A., Bång A., and Holmberg S. Hospital mortality after out of hospital cardiac arrest among patients found in ventricular fibrillation. Resuscitation 29 (1995) 11-21
20. Kern K.B., Hilwig R.W., Rhee K.H., and Berg R.A. Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning. J Am Coll Cardiol 28 (1996) 232-240
21. Gazmuri R.J., Weil M.H., Bisera J., Tang W., Fukui M., and McKee D. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 24 (1996) 992-1000
22. Vasquez A., Kern K.B., Hilwig R.W., Heidenreich J., Berg R.A., and Ewy G.A. Optimal dosing of dobutamine for treating post-resuscitation left ventricular dysfunction. Resuscitation 61 (2004) 199-207
23. Kern K.B., Hilwig R.W., Berg R.A., Rhee K.H., Sanders A.B., Otto C.W., et al. Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation 95 (1997) 2610-2613
24. Katz L.M., Wang Y., Ebmeyer U., Radovsky A., and Safar P. Glucose plus insulin infusion improves cerebral outcome after asphyxial cardiac arrest. NeuroReport 9 (1998) 3363-3367
25. Lanier W.L., Stangland K.J., Scheithauer B.W., Milde J.H., and Michenfelder J.D. The effects of dextrose infusion and head position on neurologic outcome after complete cerebral ischemia in primates: examination of a model. Anesthesiology 66 (1987) 39-48
26. Van Den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
27. Finney S.J., Zekveld C., Elia A., and Evans T.W. Glucose control and mortality in critically ill patients. JAMA 290 (2003) 2041-2047
28. Malmberg K., Rydén L., Efendic S., Herlitz J., Nicol P., Waldenström A., et al. Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI-Study). Effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
29. Malmberg K., Rydén L., Wedel H., Birkeland K., Bootsma A., Dickstein K., et al., for the DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 26 (2005) 650-661
30. Rubeiz G.J., Thill-Baharozian M., Hardie D., and Carlson R.W. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med 21 (1993) 203-209
31. Polderman K.H., van Zanten A.R., and Girbes A.R. The importance of magnesium in critically ill patients: a role in mitigating neurological injury and in the prevention of vasospasms. Intensive Care Med 29 (2003) 1202-1203
32. Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Intern Med 229 (1991) 331-335
33. Davies M.J., and Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 310 (1984) 1137-1140
34. Zipes D.P., and Wellens H.J.J. Sudden Cardiac Death. Circulation 98 (1998) 2334-2351
35. Spaulding C.M., Joly L.-M., Rosenberg A., Monchi M., Weber S.N., Dhainaut J.F.A., et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 336 (1997) 1629-1633
36. Van Campen L.C.M.C., van Leeuwen G.R., and Verheugt F.W.A. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 73 (1994) 953-955
37. Weston C.F., and Avery P. Thrombolysis following pre-hospital cardiopulmonary resuscitation. Int J Cardiol 37 (1992) 195-198
38. Scholz K.H., Tebbe U., Herrmann C., Wojcik J., Lingen R., Chemnitius J.M., et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol 69 (1992) 724-728
39. Bendz B., Eritsland J., Nakstad A.R., Brekke M., Klow N.E., Steen P.A., et al. Long-term prognosis after out-of-hospital cardiac arrest and primary precutaneous coronary intervention. Resuscitation 63 (2004) 49-53
40. Every N.R., Fahrenbruch C.E., Hallstrom A.P., Weaver W.D., and Cobb L.A. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol 19 (1992) 1435-1439
41. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 311 (1984) 1333-1339
42. Varnauskas E., and European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 319 (1988) 332-337
43. Coronary Artery Surgery Study (CASS) principal investigators, associates. CASS: a randomized trial of coronary bypass surgery. Circulation 68 (1983) 939-950
44. Yusuf S., Zucker D., Peduzzi P., Fisher L.D., Takaro T., Kennedy J.W., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 (1994) 563-570
45. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
46. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
47. Kuck K.H., Cappato R., Siebels J., Rüppel R., and for the CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. Circulation 102 (2000) 748-754
48. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
49. Connolly S.J., Hallstrom A.P., Cappato R., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian implantable Defibrillator Study. Eur Heart J 21 (2000) 2071-2078
50. Yusuf S., Peto R., Lewis J., Collins R., and Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27 (1985) 335-371
51. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-III). Arandomised trial. Lancet 353 (1999) 9-13
52. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL. Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
53. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
54. Engdahl J., Bång A., Lindqvist J., and Herlitz J. Time trends in long-term mortality after out-of-hospital cardiac arrest 1980-1998 and predictors for death. Am Heart J 145 (2003) 826-833
55. Hallstrom A.P., Cobb L.A., Yu B.H., Weaver W.D., and Fahrenbruch C.E. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 68 (1991) 1025-1031
56. Cairns J.A., Connolly S.J., Roberts R., Gent M., and for the Canadian Amiodarone Myocardial infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349 (1997) 675-682
57. Julian D.G., Camm A.J., Frangin G., et al. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 349 (1997) 667-674
58. Amiodarone, Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-24.
59. Connolly S.J. Evidence-based analysis of amiodarone efficacy and safety. Circulation 100 (1999) 2025-2034
60. Krumholz A., Stern B.J., and Weiss H.D. Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclonus. Neurology 38 (1988) 401-405
61. Snyder B.D., Hauser A., Loewenson R.B., Leppik I.E., Ramirez-Lassepass M., and Gummit R.J. Neurologic prognosis after cardiopulmonary arrest. III. Seizure activity. Neurology 30 (1980) 1292-1297
62. Ebmeyer U., Safar P., Radovsky A., Xiao F., Capone A., Tanigawa K., et al. Thiopental combination treatments for cerebral resuscitation after prolonged cardiac arrest in dogs. Exploratory outcome study. Resuscitation 45 (2000) 119-131
63. Imaizumi S., Kurosawa K., Kinouchi K., and Yoshimoto T. Effect of phenytoin on cortical Na(+)-K(+)-ATPase activity in global ischemic rat brain. J Neurotrauma 12 (1995) 231-234
64. Taft W.C., Clifton G.L., Blair R.E., and DeLorenzo R.J. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res 483 (1989) 143-148
65. Brain Resuscitation Clinical Trial. I. Study Group. Randomised clinical study of a thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 314 (1986) 397-403